Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 547,480 | 697,298 | 908,882 | 803,892 |
| Gross Profit | -547,480 | -697,298 | -908,882 | -803,892 |
| Selling General And Administration | 1.9M | 2.1M | 3.4M | 3.3M |
| General And Administrative Expense | 1.9M | 2.1M | 3.4M | 3.3M |
| Other Operating Expenses | 172,801 | 301,475 | 526,162 | 200,507 |
| Operating Expense | 2.0M | 2.4M | 3.9M | 3.5M |
| Operating Income | -2.6M | -3.1M | -4.8M | -4.3M |
| EBIT | 1.1M | -6.8M | -15.1M | -4.5M |
| Interest Expense | 2.6M | 1.8M | 1.5M | 793,068 |
| Interest Expense Non Operating | 2.6M | 1.8M | 1.5M | 793,068 |
| Net Interest Income | -2.6M | -1.8M | -1.5M | -793,068 |
| Other Income Expense | 3.7M | -3.6M | -10.3M | -147,674 |
| Special Income Charges | 2.4M | -3.6M | -10.1M | 7,124 |
| Write Off | 888,889 | 0.00 | -- | -- |
| Gain On Sale Of Security | 1.3M | 8,235 | -195,938 | -154,798 |
| Pretax Income | -1.5M | -8.6M | -16.6M | -5.3M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -1.5M | -8.6M | -16.6M | -5.3M |
| Net Income From Continuing Operation Net Minority Interest | -1.5M | -8.6M | -16.6M | -5.3M |
| Net Income Including Noncontrolling Interests | -1.5M | -8.6M | -16.6M | -5.3M |
| Net Income Common Stockholders | -1.5M | -8.6M | -16.6M | -5.3M |
| Net Income | -1.5M | -8.6M | -16.6M | -5.3M |
| EBITDA | 1.5M | -6.2M | -14.5M | -3.9M |
| Normalized EBITDA | -2.1M | -2.6M | -4.2M | -3.8M |
| Reconciled Depreciation | 434,912 | 515,003 | 624,620 | 547,991 |
| Basic EPS | -0.01 | -0.08 | -0.19 | -0.08 |
| Diluted EPS | -0.01 | -0.08 | -0.19 | -0.08 |
| Basic Average Shares | 114.7M | 111.9M | 89.4M | 64.1M |
| Diluted Average Shares | 114.7M | 111.9M | 89.4M | 64.1M |
| Total Unusual Items | 3.7M | -3.6M | -10.3M | -147,674 |
| Total Unusual Items Excluding Goodwill | 3.7M | -3.6M | -10.3M | -147,674 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -5.2M | -4.9M | -6.3M | -5.1M |
| Diluted NI Availto Com Stockholders | -1.5M | -8.6M | -16.6M | -5.3M |
| Gain On Sale Of Ppe | -- | 0.00 | -2,910 | 7,124 |
| Impairment Of Capital Assets | -3.3M | 3.6M | 10.1M | 0.00 |
| Net Income Continuous Operations | -1.5M | -8.6M | -16.6M | -5.3M |
| Net Non Operating Interest Income Expense | -2.6M | -1.8M | -1.5M | -793,068 |
| Other Gand A | 698,677 | 1.1M | 1.1M | 749,401 |
| Reconciled Cost Of Revenue | 547,480 | 697,298 | 908,882 | 803,892 |
| Salaries And Wages | 1.2M | 1.0M | 2.3M | 2.6M |
| Total Expenses | 2.6M | 3.1M | 4.8M | 4.3M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 525,643 | 2.6M | 1.0M | 1.1M |
| Cash Cash Equivalents And Short Term Investments | 525,643 | 2.6M | 1.0M | 1.1M |
| Accounts Receivable | 69,806 | 83,266 | 116,374 | 594,071 |
| Receivables | 144,445 | 108,292 | 420,653 | 998,728 |
| Inventory | 213,644 | 18,184 | 83,242 | 108,788 |
| Prepaid Assets | 219,917 | 1.5M | 1.4M | 281,207 |
| Current Assets | 1.1M | 4.2M | 2.9M | 2.5M |
| Gross PPE | 44.9M | 37.2M | 35.5M | 35.6M |
| Accumulated Depreciation | -10.4M | -9.3M | -8.6M | -8.3M |
| Net PPE | 34.4M | 27.9M | 26.9M | 27.3M |
| Total Non Current Assets | 35.0M | 28.4M | 27.4M | 27.8M |
| Total Assets | 36.1M | 32.6M | 30.3M | 30.2M |
| Current Debt | -- | 6.1M | 4.8M | -- |
| Current Debt And Capital Lease Obligation | -- | 6.1M | 4.8M | 416,040 |
| Accounts Payable | 2.0M | 2.1M | 2.5M | 1.5M |
| Payables | 15.9M | 8.0M | 7.6M | 1.6M |
| Payables And Accrued Expenses | 17.3M | 9.5M | 9.1M | 3.1M |
| Current Accrued Expenses | 1.4M | 1.5M | 1.5M | 1.6M |
| Other Current Liabilities | -- | 1.2M | -- | -- |
| Current Liabilities | 17.3M | 16.8M | 14.0M | 3.6M |
| Long Term Debt | 6.6M | 1.9M | -- | 4.2M |
| Long Term Debt And Capital Lease Obligation | 6.6M | 1.9M | -- | 4.2M |
| Other Non Current Liabilities | -- | -- | 1.1M | -- |
| Total Non Current Liabilities Net Minority Interest | 7.3M | 4.4M | 1.7M | 7.3M |
| Total Liabilities Net Minority Interest | 24.7M | 21.2M | 15.6M | 10.8M |
| Common Stock | 71.8M | 71.8M | 69.7M | 57.8M |
| Capital Stock | 71.8M | 71.8M | 69.7M | 57.8M |
| Retained Earnings | -80.5M | -79.0M | -70.5M | -53.8M |
| Gains Losses Not Affecting Retained Earnings | 20.1M | 18.6M | 15.5M | 15.4M |
| Common Stock Equity | 11.4M | 11.4M | 14.7M | 19.4M |
| Stockholders Equity | 11.4M | 11.4M | 14.7M | 19.4M |
| Total Equity Gross Minority Interest | 11.4M | 11.4M | 14.7M | 19.4M |
| Total Capitalization | 18.0M | 13.3M | 14.7M | 23.6M |
| Net Tangible Assets | 11.4M | 11.4M | 14.7M | 19.4M |
| Tangible Book Value | 11.4M | 11.4M | 14.7M | 19.4M |
| Working Capital | -16.2M | -12.6M | -11.0M | -1.1M |
| Invested Capital | 18.0M | 19.4M | 19.6M | 23.6M |
| Total Debt | 6.6M | 8.0M | 4.8M | 4.7M |
| Net Debt | 6.0M | 5.4M | 3.8M | 3.2M |
| Share Issued | 114.8M | 114.8M | 103.5M | 74.7M |
| Ordinary Shares Number | 114.8M | 114.8M | 103.5M | 74.7M |
| Capital Lease Obligations | -- | -- | 0.00 | 416,040 |
| Construction In Progress | 26.8M | 20.7M | 21.4M | 23.1M |
| Current Capital Lease Obligation | -- | -- | 0.00 | 416,040 |
| Derivative Product Liabilities | 123,542 | 1.2M | 0.00 | -- |
| Dueto Related Parties Current | 13.9M | 5.8M | 5.1M | 124,317 |
| Dueto Related Parties Non Current | 0.00 | 638,432 | 0.00 | 2.4M |
| Finished Goods | 213,644 | 18,184 | 83,242 | 108,788 |
| Line Of Credit | 0.00 | 6.1M | 4.8M | -- |
| Long Term Provisions | 666,128 | 611,452 | 582,441 | 600,525 |
| Machinery Furniture Equipment | 10.1M | 9.4M | 9.2M | 8.5M |
| Non Current Prepaid Assets | 540,870 | 505,110 | 489,660 | 513,960 |
| Other Properties | 2.5M | 2.3M | 2.3M | 2.4M |
| Other Receivables | -- | -- | -- | 160,412 |
| Taxes Receivable | 74,639 | 25,026 | 304,279 | 244,245 |
| Tradeand Other Payables Non Current | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -1.9M | -1.3M | 180,007 | -1.7M |
| Cash Flow From Continuing Operating Activities | -1.9M | -1.3M | 180,007 | -1.7M |
| Depreciation And Amortization | 434,912 | 515,003 | 624,620 | 547,991 |
| Depreciation Amortization Depletion | 434,912 | 515,003 | 624,620 | 547,991 |
| Stock Based Compensation | 431,990 | 353,712 | 1.5M | 2.0M |
| Change In Working Capital | -252,113 | 485,001 | 2.4M | 225,457 |
| Changes In Account Receivables | 356,117 | 214,113 | 438,113 | -701,573 |
| Change In Receivables | 356,117 | 214,113 | 438,113 | -701,573 |
| Change In Inventory | -195,460 | 65,058 | 21,415 | -29,200 |
| Change In Payables And Accrued Expense | -412,770 | 205,830 | 889,344 | 956,230 |
| Change In Payable | -412,770 | 205,830 | 889,344 | 956,230 |
| Change In Other Current Liabilities | -- | 0.00 | 1.1M | 0.00 |
| Other Non Cash Items | 2.5M | 2.3M | 1.9M | 667,632 |
| Capital Expenditure | -1.3M | -3.8M | -11.6M | -5.3M |
| Purchase Of PPE | -1.3M | -3.8M | -11.6M | -5.3M |
| Net PPE Purchase And Sale | -1.3M | -3.8M | -11.6M | -5.3M |
| Investing Cash Flow | -1.3M | -3.8M | -12.3M | -5.5M |
| Cash Flow From Continuing Investing Activities | -1.3M | -3.8M | -12.3M | -5.5M |
| Issuance Of Debt | 0.00 | 3.5M | 0.00 | 0.00 |
| Repayment Of Debt | -- | -- | 0.00 | -23,802 |
| Net Issuance Payments Of Debt | 0.00 | 3.5M | 0.00 | -23,802 |
| Issuance Of Capital Stock | 0.00 | 3.0M | 5.9M | 8.0M |
| Net Common Stock Issuance | 0.00 | 3.0M | 5.9M | 8.0M |
| Financing Cash Flow | 1.1M | 6.6M | 12.1M | 7.7M |
| Cash Flow From Continuing Financing Activities | 1.1M | 6.6M | 12.1M | 7.7M |
| Effect Of Exchange Rate Changes | 30,575 | 79,286 | -47,401 | -2,023 |
| Changes In Cash | -2.1M | 1.5M | 16,293 | 459,680 |
| Beginning Cash Position | 2.6M | 1.0M | 1.1M | 612,094 |
| End Cash Position | 525,643 | 2.6M | 1.0M | 1.1M |
| Free Cash Flow | -3.2M | -5.1M | -11.4M | -7.0M |
| Asset Impairment Charge | -2.4M | 3.6M | 10.1M | 0.00 |
| Change In Account Payable | -412,770 | 205,830 | 1.2M | 918,974 |
| Common Stock Issuance | 0.00 | 3.0M | 5.9M | 8.0M |
| Depreciation | 434,912 | 515,003 | 624,620 | 547,991 |
| Gain Loss On Investment Securities | -1.9M | -241,886 | -- | -- |
| Gain Loss On Sale Of PPE | -- | 0.00 | 2,910 | -7,124 |
| Long Term Debt Issuance | 0.00 | 3.5M | 0.00 | 0.00 |
| Long Term Debt Payments | -- | -- | 0.00 | -23,802 |
| Net Foreign Currency Exchange Gain Loss | 744,385 | 240,861 | 292,699 | 91,973 |
| Net Income From Continuing Operations | -1.5M | -8.6M | -16.6M | -5.3M |
| Net Long Term Debt Issuance | 0.00 | 3.5M | 0.00 | -23,802 |
| Net Other Financing Charges | 1.1M | 124,523 | 930,578 | -775,137 |
| Net Other Investing Changes | -- | -- | -701,782 | -260,743 |
| Operating Gains Losses | -1.1M | -1,025 | 295,609 | 84,849 |
| Proceeds From Stock Option Exercised | 0.00 | 31,200 | 5.3M | 495,333 |
| Sale Of PPE | -- | -- | 0.00 | 8,562 |